Enhanced β-adrenergic response in mice with dominant-negative expression of the PKD2L1 channel

Manabu Murakami1, Agnieszka M Murakami2, Takayuki Nemoto1

  • 1Department of Pharmacology, Faculty of Medicine, University of Miyazaki, Miyazaki, Miyazaki, Japan.

Plos One
|January 20, 2022
PubMed

Insights

Polycystic kidney disease (PKD) protein PKD2L1 influences heart function. Overexpressing a dominant-negative PKD2L1 in mice increased their sensitivity to adrenergic stimulation, impacting heart rhythm.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Biology
  • Genetics

Background:

  • Polycystic kidney disease (PKD) is a leading genetic cause of kidney failure.
  • PKD2L1, a PKD-related molecule, forms cation channels, but its physiological role remains unclear.
  • Understanding PKD2L1's function is crucial for PKD research.

Purpose of the Study:

  • To investigate the physiological role of PKD2L1 in cardiac function.
  • To determine the impact of dominant-negative PKD2L1 overexpression on adrenergic sensitivity and heart rhythm.

Main Methods:

  • Generation of a transgenic mouse model overexpressing a dominant-negative PKD2L1 (PKD2L1del-Tg).
  • Electrocardiography to assess heart rhythm and supraventricular premature contractions.
  • Pharmacological challenge with adrenergic agonists (isoproterenol, norepinephrine, epinephrine) to evaluate cardiac response.
  • Action potential recordings in atrial tissue.

Main Results:

  • PKD2L1del-Tg mice displayed supraventricular premature contractions and unstable R-R intervals.
  • Atria from PKD2L1del-Tg mice showed heightened sensitivity to adrenergic stimulation.
  • Isoproterenol challenge resulted in a shortened action potential duration in PKD2L1del-Tg atria.

Conclusions:

  • Overexpression of dominant-negative PKD2L1 leads to increased adrenergic sensitivity in the heart.
  • These findings suggest a role for PKD2L1 in sympathetic regulation of cardiac function.
  • PKD2L1 may be a potential target for modulating cardiac adrenergic responses.

Related Concept Videos

Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
2.6K
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
688
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.7K
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
772
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.1K
Adrenergic Receptors (Adrenoceptors): Classification01:27

Adrenergic Receptors (Adrenoceptors): Classification

Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
3.7K